Terms: = Lung cancer AND SMO, Q99835, 6608, ENSG00000128602, SMOH, Gx AND Treatment
34 results:
1. Congenital peribronchial myofibroblastic tumor (CPMT): a case report with long term follow-up and next-generation sequencing (NGS).
Zhou P; Li S; Wang W; Tang Y; Jiang L
BMC Pediatr; 2023 Apr; 23(1):184. PubMed ID: 37081446
[TBL] [Abstract] [Full Text] [Related]
2. ASPM Activates Hedgehog and Wnt Signaling to Promote Small Cell lung cancer Stemness and Progression.
Cheng LH; Hsu CC; Tsai HW; Liao WY; Yang PM; Liao TY; Hsieh HY; Chan TS; Tsai KK
Cancer Res; 2023 Mar; 83(6):830-844. PubMed ID: 36638332
[TBL] [Abstract] [Full Text] [Related]
3.
Ji W; Niu X; Yu Y; Li Z; Gu L; Lu S
Front Immunol; 2022; 13():955800. PubMed ID: 36405701
[TBL] [Abstract] [Full Text] [Related]
4. Jervine inhibits non-small cell lung cancer (NSCLC) progression by suppressing Hedgehog and AKT signaling via triggering autophagy-regulated apoptosis.
Lei W; Huo Z
Biochem Biophys Res Commun; 2020 Dec; 533(3):397-403. PubMed ID: 32972750
[TBL] [Abstract] [Full Text] [Related]
5. Combined inhibition of JAK2-STAT3 and smo-GLI1/tGLI1 pathways suppresses breast cancer stem cells, tumor growth, and metastasis.
Doheny D; Sirkisoon S; Carpenter RL; Aguayo NR; Regua AT; Anguelov M; Manore SG; Arrigo A; Jalboush SA; Wong GL; Yu Y; Wagner CJ; Chan M; Ruiz J; Thomas A; Strowd R; Lin J; Lo HW
Oncogene; 2020 Oct; 39(42):6589-6605. PubMed ID: 32929154
[TBL] [Abstract] [Full Text] [Related]
6. Scutellariabarbata D. Don extraction selectively targets stemness-prone NSCLC cells by attenuating SOX2/smo/GLI1 network loop.
Chen WW; Gong KK; Yang LJ; Dai JJ; Zhang Q; Wang F; Li XL; Xi SC; Du J
J Ethnopharmacol; 2021 Jan; 265():113295. PubMed ID: 32841701
[TBL] [Abstract] [Full Text] [Related]
7. The inhibition of microRNA-326 by SP1/HDAC1 contributes to proliferation and metastasis of osteosarcoma through promoting smo expression.
Huang JH; Xu Y; Lin FY
J Cell Mol Med; 2020 Sep; 24(18):10876-10888. PubMed ID: 32743904
[TBL] [Abstract] [Full Text] [Related]
8.
Jo E; Jang HJ; Shen L; Yang KE; Jang MS; Huh YH; Yoo HS; Park J; Jang IS; Park SJ
Integr Cancer Ther; 2020; 19():1534735420923756. PubMed ID: 32456485
[TBL] [Abstract] [Full Text] [Related]
9. Genomic testing, tumor microenvironment and targeted therapy of Hedgehog-related human cancers.
Katoh M
Clin Sci (Lond); 2019 Apr; 133(8):953-970. PubMed ID: 31036756
[TBL] [Abstract] [Full Text] [Related]
10. HERC4 exerts an anti-tumor role through destabilizing the oncoprotein smo.
Sun X; Sun B; Cui M; Zhou Z
Biochem Biophys Res Commun; 2019 Jun; 513(4):1013-1018. PubMed ID: 31010679
[TBL] [Abstract] [Full Text] [Related]
11. Triptonide inhibits lung cancer cell tumorigenicity by selectively attenuating the Shh-Gli1 signaling pathway.
Zhang M; Tan S; Yu D; Zhao Z; Zhang B; Zhang P; Lv C; Zhou Q; Cao Z
Toxicol Appl Pharmacol; 2019 Feb; 365():1-8. PubMed ID: 30610878
[TBL] [Abstract] [Full Text] [Related]
12. Vismodegib.
Meiss F; Andrlová H; Zeiser R
Recent Results Cancer Res; 2018; 211():125-139. PubMed ID: 30069764
[TBL] [Abstract] [Full Text] [Related]
13. Antitumor Efficacy of Dual Blockade of EGFR Signaling by Osimertinib in Combination With Selumetinib or Cetuximab in Activated EGFR Human NCLC Tumor Models.
Della Corte CM; Ciaramella V; Cardone C; La Monica S; Alfieri R; Petronini PG; Malapelle U; Vigliar E; Pepe F; Troncone G; Castellone MD; Troiani T; Martinelli E; Ciardiello F; Morgillo F
J Thorac Oncol; 2018 Jun; 13(6):810-820. PubMed ID: 29526823
[TBL] [Abstract] [Full Text] [Related]
14. Inhibition of Gli leads to antitumor growth and enhancement of cisplatin-induced cytotoxicity in large cell neuroendocrine carcinoma of the lung.
Ishiwata T; Iwasawa S; Ebata T; Fan M; Tada Y; Tatsumi K; Takiguchi Y
Oncol Rep; 2018 Mar; 39(3):1148-1154. PubMed ID: 29328464
[TBL] [Abstract] [Full Text] [Related]
15. [Preliminary study of exon sequence in pneumoconiosis and pneumoconiosis complicated with lung cancer using high-throughput sequencing technology].
Jiang MF; Li L; Wang Z; Zhang CL; Zhang H
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2017 Nov; 35(11):801-806. PubMed ID: 29316748
[No Abstract] [Full Text] [Related]
16. The role of the Hedgehog signaling pathway in cancer: A comprehensive review.
Skoda AM; Simovic D; Karin V; Kardum V; Vranic S; Serman L
Bosn J Basic Med Sci; 2018 Feb; 18(1):8-20. PubMed ID: 29274272
[TBL] [Abstract] [Full Text] [Related]
17. Disruption of SHH signaling cascade by SBE attenuates lung cancer progression and sensitizes DDP treatment.
Du J; Chen W; Yang L; Dai J; Guo J; Wu Y; Gong K; Zhang J; Yu N; Xie Z; Xi S
Sci Rep; 2017 May; 7(1):1899. PubMed ID: 28507311
[TBL] [Abstract] [Full Text] [Related]
18. Efficacy of continuous EGFR-inhibition and role of Hedgehog in EGFR acquired resistance in human lung cancer cells with activating mutation of EGFR.
Della Corte CM; Malapelle U; Vigliar E; Pepe F; Troncone G; Ciaramella V; Troiani T; Martinelli E; Belli V; Ciardiello F; Morgillo F
Oncotarget; 2017 Apr; 8(14):23020-23032. PubMed ID: 28416737
[TBL] [Abstract] [Full Text] [Related]
19. MiRNA-Related Genetic Variations Associated with Radiotherapy-Induced Toxicities in Patients with Locally Advanced Non-Small Cell lung cancer.
Li R; Pu X; Chang JY; Ye Y; Komaki R; Minna JD; Roth JA; Han B; Wu X
PLoS One; 2016; 11(3):e0150467. PubMed ID: 26991123
[TBL] [Abstract] [Full Text] [Related]
20. Blockade of Hedgehog Signaling Synergistically Increases Sensitivity to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small-Cell lung cancer Cell Lines.
Bai XY; Zhang XC; Yang SQ; An SJ; Chen ZH; Su J; Xie Z; Gou LY; Wu YL
PLoS One; 2016; 11(3):e0149370. PubMed ID: 26943330
[TBL] [Abstract] [Full Text] [Related]
[Next]